KIF5B-ALK fusion
|
Solid Tumor
|
KIF5B-ALK fusion
|
Solid Tumor
|
entrectinib Sensitive: C3 – Early Trials
|
entrectinib Sensitive: C3 – Early Trials
|
KIF5B-ALK fusion
|
LUAD
|
KIF5B-ALK fusion
|
LUAD
|
crizotinib Sensitive: C4 – Case Studies
|
crizotinib Sensitive: C4 – Case Studies
|